Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005-2011

Archives of Iranian Medicine

Volumn 17, Issue 9, 2014, Pages 613-620

  Mohammadali, Fatemeh ^a,b   Pourfathollah, Ali Akbar ^a,b  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Blood donors; Frequency; HBV; HCV; HIV; Syphilis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MARRIAGE; OCCUPATION; PREVALENCE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYPHILIS; VIRUS NEUTRALIZATION; WESTERN BLOTTING; ADOLESCENT; HIV INFECTIONS; IRAN; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SYPHILIS; YOUNG ADULT;

EID: 84906930264     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas and Bennett’s Principles and practice of infectious diseases. Fifth edition, USA, Churchill Livingstone Co, 2005: 3385-3386, 1451-1452, 1520.
2. Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. Transfusion-transmitted infections. JournalofTransfusional Medicine. 2007; 5: 25.
3. Buseri FI, Abidemi Muhibi M, Zaccheaus. Sero-epidemiology of transfusion -transmissible infectious disease among blood donors in Osogbo, South West Nigeria. Blood transfuse. 2009; 7(4): 293-299.
4. Deinstag JL, Isselbacker KJ. Epidemiology of HBV & HCV. In Luksamijarulkul P, Tammata N, eds. Harrison Textbook of Internal Medicine. 2001; 17: 28-30.
5. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infectious Diseases. 2010; 1471-2334.
6. Yedlapati Bhawani, P Raghava Rao, V Sudhakar. Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital of Andhra Pradesh. Biology and Medicine. 2010; 2(4): 45-48.
7. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study REDS). JAMA. 2000; 284: 229-235.
8. Khedmat H, Alavian SMM, Miri SM, Amini M, Abolghasemi H, Hajibeigi B, et al. Trends in Seroprevalence of Hepatitis B, Hepatitis C, HIV, and Syphilis Infections in Iranian Blood Donors from 2003 to 2005. Hepatitis Monthly. 2009; 9(1): 24-28.
9. WHO: Hepatitis C global prevalence. Weekly Epidemiological Record 1999): Available from: URL: http://www.who.int/docstore/wer/ pdf71999/ wer7449.pdf
10. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high-risk groups in Iran. Vox Sang. 1979; 37: 182-186.
11. Amini Kafi-abad S, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfusion Medicine. 2009; 19: 189-194.
12. Amini Kafi-abad S, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49: 2214-2220.
13. Salawu L, Bolarinwa RA, Adegunloye AB,Muraina HA. HBsAg, anti-HCV, anti-HIV and VDRL in blood donors: Prevalence and trends in the last three and a half years in a tertiary health care facility in Ile-Ife, Nigeria. International Journal of Medicine and Medical Sciences. 2010; 2(11): 335-341.
14. Irani-Hakime N, Musharrafieh U, Samaha H, Almawi WY. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003. American Journal of Infection Control. 2006; 34: 241-243.
15. Bashawari LA, Fawaz NA, Ahmad MS, Qadi, AA, Almawi WY Prevalence of sero-markers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clinical and Laboratory Haematology. 2004; 26: 225-228.
16. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur JEpidemol. 2006; 21: 299-305.
17. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bangal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World Journal of Gastroenterology. 2007; 13: 3730-3733.
18. Busch MP. HIV, HBV, and HCV: New development related to transfusion safety. Vox Sang. 2000; 78: 253-256.
19. O’Brien SF, Xi G, Fan W, Yi Q, Fearon MA, Scalia V, Goldman M. Epidemiology of hepatitis B in Canadian blood donors. Transfusion. 2008; 48: 23-25.
20. Polizzotto MN, Wood EM, Ingham H, Keller AJ. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion.2008; 48: 55-63.
21. Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian JMedSci. 2004; 58: 255-257.
22. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-T/n infections among blood donors in a teaching hospital in the central region of Saudi Arabia. Saudi Med. 2004; 25: 26-33.
23. Waqas J, Shahnawaz U. Prevalence of Hepatitis B, C and HIV in blood donors of south Punjab. Pak J Med Sci. 2005; 20(1): 24-28.
24. Dessie A, Abera B, Wale F. Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, north-west Ethiopia. Ethiop J Health Dev. 2007; 21(1): 68-69.
25. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol. 2005; 20: 229-233.
26. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2: 290-298.
27. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12: 225-231.
28. Rezvan H, Ahmadi J, Farhadi M, Tardyan S. A preliminary study of prevalence of HCV infection in healthy Iranian blood donors. Vox Sang. 1994; 67: 149.
29. Khodabandehloo M, Roushany D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. J Res Med Sci. 2013; 18: 674-682.
30. Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: A ten-year experience. Int J Infect Dis. 2007; 11: 407-412.
31. Meena M, Jindal T, Hazarika A. Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in In dia: A five-year study. Transfusion. 2011; 51: 198-202.
32. Merat SH, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. International Journal of Infectious Diseases. 2010; 14S: e113-e116.
33. Abolghasemi H, Maghsudlu M, Amini Kafi-Abad S, Cheraghali A. Introduction to Iranian blood transfusion organization and blood safety in Iran. Iran J Public Health. 2009; 38: 82-87.
34. Mahmoodian-Shooshtari M, Pourfathollah A. An overview analysis of blood donation in the Islamic Republic of Iran. Arch Iran Med. 2006; 9: 200-203.
35. Glíuck D, Koerner K, Caspari G, Elbert G, Gaus W, Gríassmann W, et al. Epidemiology of HIV in blood donors in West Germany. Dtsch Med Wochenschr. 1988; 113: 1383-1389.
36. Likatavicius G, Hamers FF, Downs AM, Alix J, Nardone A. Trends in HIV prevalence in blood donations in Europe, 1990-2004. AIDS. 2007; 21(8): 1011-1018.
37. Grosskkkurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized control trial. Lancet. 1995; 346: 530-536.
38. Massarat MS, Tahaghoghi-Mehrizad S. Iranian national health survey: A brief report. Arch Iranian Med 2002; 5: 73-79.
39. Second IR. Iran report about HIV and AIDS. 2007.
40. [In Persian]. Aymard JP, Janot C, Contal P, Linel C, Monange G, Streiff F. Epidemiologic study of HIV serology in blood donors from 5 departments in northeastern France. Ver Fr Transfus Hemobiol. 1989; 32: 421-429.
41. Petersen LR, Doll LS, White CR, Johnson E, Williams A. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. Transfus. 1993; 33: 552-557.
42. Chikwem JO, Mohammed I, Okara GC, Ukwandu NC, Ola TO. Prevalence of transmissible blood infections among blood donors at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. East Afr Med J. 1997; 4: 213-216.
43. Javadzadeh Shahshahani H. Why dont women volunteer to give blood? A study of knowledge, attitude and practice of women about blood donation, Yazd, Iran, 2005. Transfusion Medicine. 2007; 17: 451-454.
44. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop MedHyg. 1993; 96: 277-287.
45. Mahmoodian-Shooshtari M, Pourfathollah A. An overview analysis of blood donation in the Islamic Republic of Iran. Arch Iran Med. 2006; 9: 200-203